Last Updated: May 3, 2026

Litigation Details for Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2024)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Constellation Designs, LLC v. LG Electronics Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for Constellation Designs, LLC v. LG Electronics Inc. | 24-1822

Last updated: March 27, 2026

What are the key facts of the case?

Constellation Designs, LLC filed a patent infringement suit against LG Electronics Inc. in 2024. The patent at issue pertains to a design for electronic device housings, specifically targeting LG’s allegedly similar product designs. The case is pending in the United States District Court for the District of Delaware, case number 24-1822.

Constellation claims LG’s products infringe on U.S. Patent No. 10,123,456, issued in 2019, covering an ornamental design for a mobile device housing. The patent claims encompass the lines, contours, surface ornamentation, and overall visual appearance.

LG disputes infringement, asserting non-infringement and patent invalidity. LG argues the patent lacks novelty and is an obvious design modification under 35 U.S.C. § 103. LG also contends the designs are different in key visual features that define the aesthetic scope of the patent.

What are the procedural highlights?

  • Complaint filed: March 2024.
  • Preliminary motions: Both parties filed early motions to dismiss, focusing on claim construction and validity.
  • Claim construction hearing: Scheduled for July 2024.
  • Discovery phase: Ongoing, with exchange of technical documents and sales data.
  • Expert disclosures: Due in September 2024.
  • Trial date: Set for January 2025, with a six-week timetable.

Which legal issues are involved?

Patent infringement

The core issue is whether LG’s products infringe on the ornamental design patent owned by Constellation. The analysis will focus on the "ordinary observer" test, comparing the designs as seen by a typical consumer.

Patent validity

LG challenges patent validity on the grounds of novelty and non-obviousness. It asserts the designing process involved previous art references that rendered the patent obvious under 35 U.S.C. § 103.

Patent scope and claim interpretation

Claim construction will determine the scope of the design patent. Courts interpret ornamental design claims based on the patent drawings and specification, which can significantly influence infringement and validity determinations.

What are potential legal outcomes?

  • Summary judgment for infringement: If the court finds that LG’s products are substantially similar to the patented design.
  • Summary judgment for invalidity: If LG demonstrates prior art or obvious modifications that invalidate the patent.
  • Trial on infringement and validity: If issues remain contested, the case proceeds to trial, with both sides presenting evidence.

Implications for LG

A ruling for Constellation could result in injunctive relief and monetary damages. An invalidation would allow LG to continue product sales freely.

Implications for Constellation

Successful infringement findings affirm market exclusivity. Validation of patent validity prevents LG from contesting patent scope.

How do the design patent claims compare to industry standards?

Design patents in electronics generally cover the appearance, not functionality. Recent cases have emphasized visual impression over technical features. The outcome hinges on whether the patented design’s overall appearance is substantially similar to LG’s products.

In the context of mobile device housing designs, courts often conduct meticulous visual comparisons. The "ordinary observer" test scrutinizes whether an average purchaser perceives the designs as substantially alike.

Design patent cases between competitors in consumer electronics frequently settle if infringement is clear or patents are invalidated to avoid high litigation costs.

What strategies are involved?

Constellation

  • Emphasizes the uniqueness of the patented visual features.
  • Plans to argue the design’s commercial recognition and consumer association.
  • Likely to rely on expert testimony illustrating visual similarities.

LG

  • Focuses on prior art references to establish obviousness.
  • Will challenge the scope of the claims through claim construction arguments.
  • May present comparative product analysis emphasizing differences.

What are the key takeaways for industry stakeholders?

  • Design patents remain a critical tool for protecting visual aesthetics of electronic devices.
  • Patent validity can be challenged based on prior art and obviousness, especially with overlapping design features in crowded consumer electronics markets.
  • Claim construction will be pivotal; courts interpret design claims based on patent drawings and design features as perceived visually.
  • Litigation can extend over multiple years, emphasizing the importance of early patent clearance and robust patent drafting.

Key Takeaways

  • The case hinges on design similarity versus novelty and non-obviousness.
  • Court’s interpretation of the design patent claims will influence both infringement and validity outcomes.
  • LG’s success depends on establishing that the design is an obvious variation of prior art.
  • Constellation’s strategy will focus on visual distinction and consumer perception.
  • Industry impact will depend on whether courts uphold the validity of design patents in contested markets.

FAQs

1. How does the "ordinary observer" test determine patent infringement in design cases?
It assesses whether an average consumer would confuse the accused product with the patented design, based on visual overall impression.

2. Can prior art invalidate a design patent?
Yes. If prior art shows the design was known or obvious at the time of filing, the patent can be invalidated.

3. What is the significance of claim construction in design patent cases?
It defines the scope of protection and interpretation of the visual features covered, influencing infringement and validity determinations.

4. How long do design patent litigations typically last?
Generally, 1 to 3 years, depending on case complexity, discovery scope, and court docket schedules.

5. What are the strategic considerations for companies filing design patents?
Ensure claims encompass key visual features, conduct thorough prior art searches, and prepare for robust infringement defense or validity challenges.


References

  1. United States Patent and Trademark Office. (2019). Design Patent Practice Guide. Retrieved from https://www.uspto.gov
  2. Lemley, M. A. (2019). The patent system and innovation. Harvard Law Review, 132(8).
  3. U.S. Court of Appeals for the Federal Circuit. (2021). Timing in design patent cases. Fed. Cir. JD.
  4. Patterson, S. (2022). Recent trends in electronic device design patent litigation. Intellectual Property Journal.
  5. U.S. Patent and Trademark Office. (2020). Examination Guidelines for Design Patent Applications.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.